Apparatus and methods for delivery of multiple distributed stents

Details for Australian Patent Application No. 2004229355 (hide)

International Classifications

Event Publications

10 November 2005 PCT application entered the National Phase

PCT publication WO2004/091441 Priority application(s): WO2004/091441

13 March 2008 Application Accepted

Published as AU-B-2004229355

10 July 2008 Standard Patent Sealed

21 August 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 15 May 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2004261459 3, 4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators Astex Therapeutics Limited The nature of the amendment is: Amend the named inventors to remove Navarro, Eva Figueroa. Address for service in Australia - Davies Collison C

15 January 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 15 May 2008

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.